ETTNO Trial – Liberal versus Restrictive Red Blood Cell Transfusion in Extremely Low-Birth-Weight Infants
ETTNO · JAMA · 2020
The ETTNO (Effects of Transfusion Thresholds on Neurodevelopmental Outcome) trial was a multicentre, randomized controlled trial involving 1013 extremely low-birth-weight (ELBW) infants weighing 400–999 g at birth. It compared liberal (higher) versus restrictive (lower) red blood cell transfusion thresholds based on postnatal age and clinical condition (critical versus noncritical). The primary outcome was death or neurodevelopmental impairment at 24 months of corrected age. The primary outcome occurred in 44.4% of infants in the liberal group versus 42.9% in the restrictive group, showing no statistically significant difference. The study concluded that maintaining higher haemoglobin levels through liberal transfusion strategies did not improve survival without neurodevelopmental impairment.
Primary outcome (death or neurodevelopmental impairment at 24 months):
Liberal group: 44.4%.
Restrictive group: 42.9%.
No statistically significant difference (P = 0.72).
Mortality at 24 months:
Liberal group: 8.3%.
Restrictive group: 9.0%.
No significant difference.
Transfusion requirements:
Liberal group: 81.3% received at least one transfusion.
Restrictive group: 60.5% received at least one transfusion.
Median transfused volume:
Liberal group: 40 mL.
Restrictive group: 19 mL.
No significant differences in cognitive impairment, cerebral palsy, BPD or severe ROP.
Liberal transfusion strategy did not improve survival without neurodevelopmental impairment.
Open-label trial, although outcome assessors were blinded.
Some loss to follow-up at 24 months.
Findings are primarily applicable to ELBW infants weighing less than 1000 g.
Long-term outcomes beyond 24 months were not assessed in the primary report.
Differences in transfusion practices between centres may influence generalizability.
Liberal transfusion strategy did not improve survival or neurodevelopmental outcomes.
Restrictive strategy significantly reduced the proportion of infants requiring transfusion.
Higher haemoglobin thresholds do not necessarily translate into better neurodevelopmental outcomes.